Absolut Skin Spf 50 Moisturizing Sunscreen Cream
NDC Package 84066-105-01
Package Information
Absolut Skin Spf 50 Moisturizing Sunscreen (ethylhexyl methoxycinnamate, ethylhexyl salicylate, methylene bis-benzotriazolyl tetramethylbutylphenol, octocrylene) cream is ahigh-performance sunscreen providing broad-spectrum UVA/UVBprotection while hydrating and soothing the skin.This lightweight,non-greasy formula is infused with advanced UV filters, Vitamin E. This formulation utilizes a cream delivery system. Marketed by Guangzhou Tata Biotechnology Co., Ltd., this product is identified by NDC 84066-105 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 84066 - Guangzhou Tata Biotechnology Co., Ltd.
- 84066-105 - Absolut Skin Spf 50 Moisturizing Sunscreen
- 84066-105-01 - 50 mL in 1 BOTTLE
- 84066-105 - Absolut Skin Spf 50 Moisturizing Sunscreen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84066-105-01 identifies a specific commercial package of 50 ml in 1 bottle of Absolut Skin Spf 50 Moisturizing Sunscreen, a human over the counter drug labeled by Guangzhou Tata Biotechnology Co., Ltd.. This cream is formulated for topical use and contains ethylhexyl methoxycinnamate; ethylhexyl salicylate; methylene bis-benzotriazolyl tetramethylbutylphenol; octocrylene as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Tata Biotechnology Co., Ltd. on April 10, 2025. The current certification is valid through December 31, 2026.
How is this Guangzhou Tata Biotechnology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84066010501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.